Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
40
VNDA Quote, Financials, Valuation and Earnings
Last price:
$7.54
Seasonality move
:
-6.56%
Day range:
$7.35 - $7.74
52-week range:
$3.81 - $9.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.13x
P/B ratio:
0.98x
Volume:
905.4K
Avg. volume:
2.5M
1-year change:
75.8%
Market cap:
$455M
Revenue:
$198.8M
EPS (TTM):
-$1.43
VNDA Analysts' Consensus Rating
The 4 analysts providing 12-month price projections for Vanda Pharmaceuticals, Inc. shares anticipate an average target of $13.63, ranging from a low estimate of $7.50 to a high estimate of $22.00. This average target implies a growth of 76.95% compared to the current stock price of $7.70.
Consensus Price Target
$13.63
Highest Price Target
$22.00
Lowest Price Target
$7.50
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 3 | 3 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Buy | Buy |
VNDA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 12.55% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.48% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.59% over the past day.
